The Developing Country Vaccines Manufacturers Network (DCVMN) is hosting its annual general meeting in São Paulo, Brazil from October 16 – 18, 2024. With the theme, “Steering change to augment vaccine access & environmental sustainability” the meeting brings together more than 400 manufacturers, government officials, academics, and industry experts to share the latest advances in vaccine science, policy, and technology. USP is a silver sponsor of this year’s event.
USP participation
Parallel session: Bridging regulatory gaps: Navigating vaccine approval in LMICs
Thursday, October 17, 8:00 am – 8:25 am BRT
This session explores regulatory gaps and challenges for vaccine manufacturers in low- and middle-income countries, highlighting experiences from African manufacturers. This session will also explore ways to build regulatory capacity for vaccine approval for market use.
Speakers:
Laura Martin, Vaccines Program Director, Global Health and Manufacturing Services, USP Petro Terblanche, CEO, Afrigen Biologics
Session 6: Novel technologies
Thursday, October 17, 3:00 pm – 4:00 pm BRT
This session features presentations from Merck, Rommelag, Adjuvant Capital, and USP to highlight new vaccine technologies, including novel applications in mRNA manufacturing and vaccine delivery. USP will highlight tools and resources for manufacturers and regulators that support quality-assured manufacturing, packaging, and release processes for vaccines.
USP speaker:
Kevin Carrick, Senior Director, Biologics Science & Standards, USP
View the program: https://dcvmn.org/annual-general-meetings/
Not able to join? Follow us @USPGlobalHealth for updates. #DCVMNAGM
Improving access to vaccines
Building regulatory, laboratory, and manufacturing capabilities to improve health equity
Learn more
mRNA vaccines
Draft guidance on analytical procedures for mRNA vaccine quality.
Download and comment
Biologics
Analytical tools, standards, and solutions for biologics and vaccines.
Learn more